Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where P. Moulin is active.

Publication


Featured researches published by P. Moulin.


Diabetes & Metabolism | 2012

Severe hypertriglyceridaemia in patients treated with lipid-modifying agents

G. Désaméricq; E. Van Ganse; Marie-Sophie Schwalm; A. Bourke; P. Moulin

Diabetes & Metabolism - In Press.Proof corrected by the author Available online since mercredi 11 avril 2012


Revue D Epidemiologie Et De Sante Publique | 2009

Prise en charge des patients dyslipidémiques dans cinq pays européens : résultats préliminaires de l’étude LIPIDE

G. Desamericq; L. Laforest; Marie-Sophie Schwalm; P. Moulin; E. Michel; C. Eteve; G. Coffin; Cécile Ritleng; E. Van Ganse

© 2019 E Prise en charge des patients dyslipidémiques dans cinq pays européens : résultats préliminaires de l’étude LIPIDE G. Desamericq , L. Laforest , M.-S. Schwalm , P. Moulin , E. Michel , C. Eteve , G. Coffin , C. Ritleng , E. Van Ganse a a Unité de pharmacoépidémiologie, service neurologie, hôpital PierreWertheimer, CHU de Lyon, 69677 Bron, France b Cegedim Strategic Data France, Boulogne, France c Endocrinologie, 69677 Bron, France


British Journal of Clinical Pharmacology | 2005

Ineffectiveness of lipid‐lowering therapy in primary care

E. Van Ganse; T. Souchet; L. Laforest; P. Moulin; M Bertrand; P. Le Jeunne; Noémie Travier; D. Yin; Evo Alemao; G. de Pouvourville


Atherosclerosis | 2006

Long-term achievement of the therapeutic objectives of lipid-lowering agents in primary prevention patients and cardiovascular outcomes: an observational study.

E. Van Ganse; T. Souchet; L. Laforest; P. Moulin; M Bertrand; P. Le Jeunne; Stephanie Chretin; D. Yin; Evo Alemao; G. de Pouvourville


Nutrition Metabolism and Cardiovascular Diseases | 2007

Use of margarine enriched in phytosterols by patients at high cardiovascular risk and treated by hypolipidemic drugs.

Laurent Laforest; P. Moulin; Marie-Sophie Schwalm; Philippe Le Jeunne; Stephanie Chretin; Brice Kitio; Jacques Massol; Eric Van Ganse


Archive | 2009

Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs Prévalence du HDL-cholesterol bas et de l'hypertriglycéridémie chez des patients traités par hypolipidémiant

L. Laforest; T. Souchet; P. Moulin; Cécile Ritleng; G. Desamericq; Philippe Le Jeunne; Marie-Sophie Schwalm; Eric Van Ganse


Revue D Epidemiologie Et De Sante Publique | 2008

Atteinte de l’objectif thérapeutique en LDL-cholestérol selon le traitement hypolipidémiant chez des patients dyslipidémiques suivis en médecine générale

G. Desamericq; L. Laforest; T. Souchet; Cécile Ritleng; P. Moulin; Marie-Sophie Schwalm; E. Van Ganse


Value in Health | 2004

CV2 CHOLESTEROL ATTAINMENT IN DYSLIPIDAEMIC TREATED PATIENTS AND INCIDENCE OF CARDIOVASCULAR EVENTS IN CLINICAL PRACTICE

E. Van Ganse; T. Souchet; L. Laforest; P. Moulin; M Bertrand; P. Le Jeunne; Stephanie Chretin; D. Yin; Evo Alemao; G. de Pouvourville


Atherosclerosis Supplements | 2004

M.671 Effectiveness of lipid-lowering therapy in primary care in France

E. Van Ganse; P. Moulin; M Bertrand; T. Souchet; Guilhem Pietri; Evo Alemao; D. Yin; G. de Pouvourville


Value in Health | 2003

PCV3 EFFECTIVENESS OF LIPID-LOWERING THERAPY IN PRIMARY CARE IN FRANCE

E. Van Ganse; P. Moulin; M Bertrand; T. Souchet; Guilhem Pietri; D. Yin; G. de Pouvourville

Collaboration


Dive into the P. Moulin's collaboration.

Top Co-Authors

Avatar

L. Laforest

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge